Literature DB >> 21791614

p300-Dependent ATF5 acetylation is essential for Egr-1 gene activation and cell proliferation and survival.

David X Liu1, Dongmeng Qian, Bin Wang, Jin-Ming Yang, Zhimin Lu.   

Abstract

ATF5 has been shown to be a critical regulator of cell proliferation and survival; however, the underlying mechanism remains largely unknown. We demonstrate here that ATF5 interacts with the transcriptional coactivator p300, which acetylates ATF5 at lysine-29 (K29), which in turn enhances the interaction between ATF5 and p300 and binding of the ATF5/p300 complex to the ATF5 response element (ARE) region of the Egr-1 promoter. ARE-bound ATF5/p300 acetylates lysine-14 (K14) of nucleosomal histone H3 at both the ARE and serum response element (SRE) of the Egr-1 promoter, which facilitates binding of extracellular signal-regulated kinase (ERK)-phosphorylated Elk-1 to the SRE, activating the Egr-1 promoter. Interference of p300-dependent acetylation of ATF5 or nucleosomal histone H3 or blockade of ERK-dependent Elk-1 phosphorylation abrogates ATF5-dependent Egr-1 activation and cell proliferation and survival. These findings assign a central role for the ATF5/p300 complex in ATF5 function and suggest that coordinated actions by ATF5, p300, Elk-1, and ERK/mitogen-activated protein kinase (MAPK) are essential for ATF5-dependent Egr-1 activation and cell proliferation and survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791614      PMCID: PMC3165717          DOI: 10.1128/MCB.05887-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Clonogenic assay of cells in vitro.

Authors:  Nicolaas A P Franken; Hans M Rodermond; Jan Stap; Jaap Haveman; Chris van Bree
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Acetylation is indispensable for p53 activation.

Authors:  Yi Tang; Wenhui Zhao; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

3.  EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat.

Authors:  Wei Han; Gui-Nan Liu
Journal:  Life Sci       Date:  2009-12-16       Impact factor: 5.037

4.  The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines.

Authors:  Eduardo Parra; Jorge Ferreira
Journal:  Oncol Rep       Date:  2010-04       Impact factor: 3.906

5.  The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines.

Authors:  Sara E Monaco; James M Angelastro; Matthias Szabolcs; Lloyd A Greene
Journal:  Int J Cancer       Date:  2007-05-01       Impact factor: 7.396

6.  Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1/NF-kappaB synergy.

Authors:  Jiajia Ma; Zijia Ren; Yang Ma; Lu Xu; Ying Zhao; Chaogu Zheng; Yinghui Fang; Ting Xue; Baolin Sun; Weihua Xiao
Journal:  J Biol Chem       Date:  2009-10-16       Impact factor: 5.157

7.  A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.

Authors:  Zhi Sheng; Li Li; Lihua J Zhu; Thomas W Smith; Andrea Demers; Alonzo H Ross; Richard P Moser; Michael R Green
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

Review 8.  The transcription factor ATF5: role in neurodevelopment and neural tumors.

Authors:  Lloyd A Greene; Hae Young Lee; James M Angelastro
Journal:  J Neurochem       Date:  2008-11-15       Impact factor: 5.372

9.  Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells.

Authors:  Guangfu Li; Wenhong Li; James M Angelastro; Lloyd A Greene; David X Liu
Journal:  Mol Cancer Res       Date:  2009-06-16       Impact factor: 5.852

10.  Highly compacted chromatin formed in vitro reflects the dynamics of transcription activation in vivo.

Authors:  Guohong Li; Raphael Margueron; Guobin Hu; David Stokes; Yuh-Hwa Wang; Danny Reinberg
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

View more
  26 in total

1.  ATF5 is an essential protein in the centrosome.

Authors:  Kathleen Lengel; Eugene Kim; David X Liu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Targeting ATF5 in Cancer.

Authors:  James M Angelastro
Journal:  Trends Cancer       Date:  2017-06-13

Review 3.  Chromatin-tethered MAPKs.

Authors:  Aileen M Klein; Elma Zaganjor; Melanie H Cobb
Journal:  Curr Opin Cell Biol       Date:  2013-02-20       Impact factor: 8.382

4.  miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.

Authors:  Mengyuan Wang; Ming Hu; Zhaohua Li; Dongmeng Qian; Bin Wang; David X Liu
Journal:  Biochem Biophys Res Commun       Date:  2017-06-07       Impact factor: 3.575

5.  Expression and targeting of transcription factor ATF5 in dog gliomas.

Authors:  D York; C D Sproul; N Chikere; P J Dickinson; J M Angelastro
Journal:  Vet Comp Oncol       Date:  2017-05-08       Impact factor: 2.613

6.  Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.

Authors:  Joseph D Dekker; Daechan Park; Arthur L Shaffer; Holger Kohlhammer; Wei Deng; Bum-Kyu Lee; Gregory C Ippolito; George Georgiou; Vishwanath R Iyer; Louis M Staudt; Haley O Tucker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

Review 7.  Mitochondrial Stress Response and Cancer.

Authors:  Jordan O'Malley; Rahul Kumar; Joseph Inigo; Nagendra Yadava; Dhyan Chandra
Journal:  Trends Cancer       Date:  2020-05-22

8.  SUMO2/3 modification of activating transcription factor 5 (ATF5) controls its dynamic translocation at the centrosome.

Authors:  Yunsheng Yuan; Kari Gaither; Eugene Kim; Edward Liu; Ming Hu; Kathy Lengel; Dongmeng Qian; Yidi Xu; Bin Wang; Henning Knipprath; David X Liu
Journal:  J Biol Chem       Date:  2018-01-11       Impact factor: 5.157

9.  EGR-1 plays a protective role in AMPK inhibitor compound C-induced apoptosis through ROS-induced ERK activation in skin cancer cells.

Authors:  Kai-Cheng Chuang; Fan-Wen Chen; Meng-Hsiun Tsai; Jeng-Jer Shieh
Journal:  Oncol Lett       Date:  2021-02-19       Impact factor: 2.967

10.  p300-dependent acetylation of activating transcription factor 5 enhances C/EBPβ transactivation of C/EBPα during 3T3-L1 differentiation.

Authors:  Yue Zhao; Ya-Dong Zhang; You-You Zhang; Shu-Wen Qian; Zhi-Chun Zhang; Shu-Fen Li; Liang Guo; Yuan Liu; Bo Wen; Qun-Ying Lei; Qi-Qun Tang; Xi Li
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.